Mount Sinai researchers have made two important discoveries about the mechanism by which bladder cancer cells foil attacks from the immune system. The research, published in Cancer Cell in September, could lead to a new therapeutic option for patients with these types of tumors.
According to new research, mice with colorectal cancer who have tumours with high levels of ammonia have fewer T cells and are less responsive to immunotherapy. Ammonia, which is crucial for anti-tumor immunity, has been demonstrated to impede the proliferation and operation of T cells.
Researchers found and developed nanoparticles that simultaneously carry chemotherapy and a new immunotherapy. Chemotherapy is a pillar of cancer treatment, but residual cancer cells can persist and cause tumor relapse.
The study found protein is crucial in helping malignancies avoid immune attacks. The "fragile X mental retardation protein" (FMRP) is a protein that controls a network of genes and cells in the tumor microenvironment that help the tumor "hidden" from immune cells.
In a new study, researchers from UC San Francisco and Vanderbilt University Medical Center identified particular immune cells that cause lethal cardiac damage in a small subsection of cancer immunotherapy patients.
Vienna [Austria], October 10 (ANI): A Mediterranean diet high in fibre, monounsaturated fatty acids, and polyphenols has been linked to improved immunotherapy response rates and progression-free survival in patients with advanced melanoma, according to a new study.
Washington [US], August 8 (ANI): Genetic signatures that can predict whether tumours in patients with bladder and other cancers will respond to immunotherapy have recently been identified by researchers from Cedars-Sinai Cancer.
Houston [US], June 4 (ANI): Researchers have developed an ultrasound-guided cancer immunotherapy platform that promotes systemic antitumor immunity and increases immune checkpoint blockade therapeutic efficacy, according to the University of Texas MD Anderson Cancer Center.
New York [US], June 2 (ANI): Mount Sinai researchers have proven that a simple blood test called a liquid biopsy can be a stronger predictor of whether cancer immunotherapy will work for a patient with lung cancer than an invasive tumour biopsy technique.
Houston [US], May 30 (ANI): According to the University of Texas MD Anderson Cancer Center, researchers have developed an ultrasound-guided cancer immunotherapy platform that promotes systemic antitumor immunity and increases immune checkpoint blockade therapeutic efficacy.